CIBC World Market
VERV

CIBC World Market’s Verve Therapeutics VERV Stock Holding History

CIBC World Market’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,044
Closed -$73.3K – 1481
2025
Q1 		$73.3K Sell
16,044
-1,682
-9% -$11.3K ﹤0.01% 1318
2024
Q4 		$100K Buy
17,726
+2,154
+14% +$12.1K ﹤0.01% 1318
2024
Q3 		$75K Sell
15,572
-2,258
-13% -$13.1K ﹤0.01% 1268
2024
Q2 		$87K Sell
17,830
-1,373
-7% -$8.63K ﹤0.01% 1224
2024
Q1 		$255K Sell
19,203
-411
-2% -$5.45K ﹤0.01% 1159
2023
Q4 		$273K Buy
19,614
+566
+3% +$7.02K ﹤0.01% 1093
2023
Q3 		$253K Buy
+19,048
New +$307K ﹤0.01% 1068
2022
Q2 		– Sell
-12,474
Closed -$285K – 1374
2022
Q1 		$285K Buy
+12,474
New +$357K ﹤0.01% 1102
2021
Q4 		– Sell
-9,239
Closed -$434K – 1424
2021
Q3 		$434K Buy
+9,239
New +$544K ﹤0.01% 1015

Other funds holding VERV

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CIBC World Market's VERV Position: Q2 2025 in Review

CIBC World Market sold out of Verve Therapeutics (VERV) in Q2 2025, closing a stake of 16,044 shares — an estimated $73.3K sold.

CIBC World Market first reported a position in VERV in Q3 2021 and held it in 9 quarters. The position peaked at $434K in Q3 2021. 175 funds tracked by Wall St. Rank hold VERV as of Q2 2025.

  • CIBC World Market reported no remaining Verve Therapeutics position as of Q2 2025 after selling out during the quarter.
  • CIBC World Market sold 16,044 Verve Therapeutics shares in Q2 2025, an estimated $73.3K.
  • CIBC World Market first reported a position in Verve Therapeutics in Q3 2021 and held it in 9 quarters.
  • CIBC World Market's Verve Therapeutics position peaked at $434K in Q3 2021.
  • 175 funds tracked by Wall St. Rank held Verve Therapeutics as of Q2 2025.

Based on CIBC World Market's 13F filing for Q2 2025, filed 14 Aug 2025.